Over the past four decades, remarkable progress has been made in understanding HIV epidemiology, pathogenesis, treatment, and prevention from the combined efforts of community members, clinicians, investigators, and funding agencies worldwide. Yet more work and new approaches are needed to achieve the ambitious goal of ending the epidemic and ensuring optimal quality of life for those living with HIV. To encourage and stimulate the next generation of investigators, the CROI Program Committee organizes an annual Workshop for New Investigators and Trainees comprised of expert and comprehensible talks to cover current knowledge and controversies in basic, clinical and public health investigation into HIV and related infections, and to highlight relevant work to be presented over the ensuing days at CROI. This year, the presentations will cover both HIV and SARS-CoV-2. The program will begin with a presentation by Dr Frank Kirchhoff on novel aspects of the HIV-1 and SARS-CoV-2 replication cycles, with an emphasis on the similarities and differences between the two viruses. Following this, Dr Galit Alter will cover the immune responses (with a particular focus on B- and T- cell responses) against HIV and SARS-CoV-2. Dr Jürgen Rockstroh will outline the most efficient prevention measures for controlling the COVID-19 pandemic and will review new testing technologies as well as therapeutic strategies and currently available SARS-CoV-2 vaccines. In the next presentation, Jean-Michel Molina will address advances in different biomedical strategies for prevention of HIV transmission, with an emphasis on the recent development in preexposure prophylaxis (PrEP) but also some of the emerging strategies to limit SARS-CoV-2 transmission. Finally, Dr Katharine Bar will review advances in characterizing the size and composition of the replication- and rebound-competent HIV-1 reservoirs as well as highlight several preclinical and clinical approaches for functional or sterilizing HIV-1 cure. By the completion of the workshop, attendees will have achieved a head start toward maximizing the knowledge gained and research ideas arising from CROI 2021.